UCSF Helen Diller Family Comprehensive Cancer Center

Tuesday, February 17th @ucsfhealth.bsky.social BRCA and Hereditary Cancer Workshop - Helping Your Family Get Tested: Next Steps After a Positive Test Result. Panel discussion, all are welcome

Tuesday, February 17th, our latest @ucsfhealth.bsky.social educational workshop for mutation carriers and family members: BRCA and Hereditary Cancer Workshop - Helping Your Family Get Tested: Next Steps After a Positive Test Result.

Panel disucssion plus Q&A calendar.ucsf.edu/event/brca-a...

Isaac Chan, MD, PhD from UT Southwestern Medical Center

Today 2/6 at 4pm: Friday Cancer Center Seminar Series @ucsanfrancisco.bsky.social | Isaac Chan, MD, PhD from UT Southwestern Medical Center presents "Using innate barriers to treat metastatic breast cancer" Hosted by @andreigoga.bsky.social
Info: cancer.ucsf.edu/seminars

New breast cancer treatment trial at UCSF aims to avoid invasive surgery for patients Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

Do patients with a non-invasive type of #BreastCancer need surgery to prevent progression—or is it better to hold off & carefully monitor their condition? A @ucsfcancer.bsky.social clinical trial focuses on determining the best approach for patients with #DCIS.
https://ucsfh.org/4ryI13X

YouTube video by UCSF Cancer World Cancer Day: Voices of the UCSF Global Cancer Program

Today on #WorldCancerDay, our @ucsanfrancisco.bsky.social Global Cancer Program celebrates the power of education, training, and mentorship to empower collaborators around the world. www.youtube.com/watch?v=Xi9T...

Miller Huang, PhD

Fri 1/30 at 4pm: @ucsanfrancisco.bsky.social Cancer Center Friday Seminar Series | Miller Huang, PhD @keckmedicineusc.bsky.social presents "Using human pluripotent stem cells to model tumorigenesis and identify therapeutic targets in pediatric neural tumors"
cancer.ucsf.edu/seminars

Join us March 21-22 for our UCSF Radiation Oncology Update: The Science and Practice of Reirradiation - a focused training and update on the scientific bases and technological advances enabling reirradiation! Details, Agenda ucsf.cloud-cme.com/course/cours... @ucsfcancer.bsky.social

New study seeks to tailor RLT to individual patients The RECIPROCAL trial is seeking to enroll approximately 1,500 participants with prostate cancer nationwide.

“We hope to prove we can safely adjust the therapy based on an individual’s cancer instead of sticking to a rigid schedule,” Dr. Thomas Hope @ucsfhealth.bsky.social on study optimizing targeted radioligand therapy to minimize side effects for prostate cancer Tx www.auntminnie.com/clinical-new...

Congratulations to David Raleigh on being appointed Translational Science Co-Vice Chair of the NRG Brain Tumor Committee! @neurosurgucsf.bsky.social @neurosurgucsf.bsky.social @ucsfcancer.bsky.social

Quote card showing Mitchel Berger, MD, from University of California, San Francisco, in a lab coat and scrubs. Berger is a President's Cancer Panel Member and said: The three priority areas presented in this report are vital to addressing the challenges facing today's cancer workforce. Together, we can build and maintain a robust cancer workforce to meet the needs of all Americans.

We’re excited to share a new report from the President’s Cancer Panel that highlights opportunities to strengthen America’s cancer workforce. Read the full report, which was co-authored by UCSF's Mitchel Berger, MD: prescancerpanel.cancer.gov/reports-meet...
@ucsfcancer.bsky.social

Omar Abdel-Wahab, MD, Chair of Molecular Pharmacology Program, Sloan Kettering Institute; Attending Physician, Memorial Sloan Kettering Cancer Center.

Today 1/19 at 4pm: @ucsanfrancisco.bsky.social Cancer Center Friday Seminar Series: Omar Abdel-Wahab, MD @mskcancercenter.bsky.social presents "Understanding and Targeting Aberrant RNA Splicing in Cancer" cancer.ucsf.edu/seminars

Join us in being a part of the change by reserving a table for our 2nd RISE UP for Breast Cancer and Women’s Health Satellite Luncheon on Thursday, February 19th, 2026, at 12:00pm at the Hotel Nikko… ... Join us in being a part of the change by reserving a table for our 2nd RISE UP for Breast Cancer and Women’s Health Satellite Luncheon on Thursday, February 19th, 2026, at 12:00pm at the Hotel Nikko i...

So excited for our second annual RISE UP luncheon on February 19! Join us!!

www.linkedin.com/posts/laura-...

Award graphic showing a photo of UCSF neurosurgeon Shawn Hervey-Jumper, MD. Text below he photo says that a new member of the American Society for Clinical Investigation.

Congratulations to UCSF neurosurgeon scientist Shawn Hervey-Jumper, MD, on being elected to @the-asci.org! 🎉 His election recognizes the significant research contributions he has made towards our understanding of glioblastoma. @ucsfcancer.bsky.social

Sean Morrison, PhD

Today 1/9 at 4pm: UCSF Cancer Center Friday Seminar Series | Sean Morrison, PhD @seanjmorrison.bsky.social Founding Director, @cri-utsw.bsky.social presents "Immune regulation of melanoma metastasis" cancer.ucsf.edu/seminars Hosted by @rushika-perera.bsky.social @ucsanfrancisco.bsky.social

ucsf tanning bed

Great to see research on tanning bed and cancer risk from @bishaltandukar.bsky.social @shainlab.bsky.social on today’s @ucsanfrancisco.bsky.social Town Hall www.ucsf.edu/news/2025/12... #UCSFCancerProud

Risk-Based vs Annual Breast Cancer Screening | Laura Esserman | 14 comments We presented the WISDOM trial results this morning at the San Antonio Breast Cancer Symposium. We were thrilled with the incredibly positive reception of the very remarkable results. Dr. Eric Winer, M...

WISDOM is the beginning of risk-based screening. Not the end. Given the billions of dollars spent annually on screening in the US alone, we owe it to women to work to find ways to improve screening. I’m thrilled to share the results from WISDOM 1.0!

www.linkedin.com/posts/laura-...

“Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers Achieve Life Sciences ($ACHV) is near FDA approval of cytisinicline as a safe, effective treatment for smoking addiction.

Maya Vijayaraghavan, MD, MAS, CTCRE Fellowship Co-Director, was recently interviewed for an article in Hunterbrook in which she discusses the benefits of cytisinicline for smoking cessation.

Read here: hntrbrk.com/achieve/

New prostate cancer trial seeks to reduce toxicity without sacrificing efficacy The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted radi...

“Our goal... to strategically improve both survival & quality of life for men living w/ advanced prostate cancer” Thomas Hope, MD @ucsfhealth.bsky.social | New prostate cancer trial seeks to reduce toxicity w/out sacrificing efficacy @eurekalert.bsky.social www.eurekalert.org/news-release...

Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits Gene regulatory networks encode the fundamental logic of cellular functions, but systematic network mapping remains challenging, especially in cell states relevant to human biology and disease. Here, ...

Together with @ronghuizhu.bsky.social, we are thrilled to present our new perturb-seq study of 22M primary CD4+ T cells, across donors and timepoints – the result of a decade-long collaboration between the Marson @marsonlab.bsky.social and Pritchard @jkpritch.bsky.social labs 🧵 tinyurl.com/gwt2025

Tanning beds are actually changing your DNA in this potentially deadly way: ‘Never been shown before’ Despite coming back in style, the dangers of tanning beds never went away, particularly one side effect that’s more than skin deep and literally changing DNA.

Step away from the tanning bed. Collaborative research from @shainlab.bsky.social @ucsanfrancisco.bsky.social and Northwestern nypost.com/2025/12/21/h...

Congrats to @sjohnliu.bsky.social named 1 of 3 recipients of this yr’s Distinguished Scientist Award from The Sontag Foundation! It will support research using new functional genomic techniques to find better therapies for glioblastoma @neurosurgucsf.bsky.social @ucsfcancer.bsky.social

Drs. Eric Small and Ana Velasquez Manana at ASCO

Kudos to Ana I. Velázquez Mañana, MD, MSc, FASCO @ucsfhealth.bsky.social (seen here with @ucsanfrancisco.bsky.social mentor and current @ascocancer.bsky.social President Dr. Eric Small) on being elected to the ASCO Nominating Committee. www.asco.org/about-asco/p...

Blue light tanning bed

“We found that tanning bed users in their 30s and 40s had even more mutations than people in the general population who were in their 70s and 80s” @bishaltandukar.bsky.social @shainlab.bsky.social on latest study from @ucsanfrancisco.bsky.social & Northwestern Univ cancer.ucsf.edu/news/2025/12...

Good news keeps coming! Excited to share our latest preprint expanding myeloid cell editing capabilities: Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells, led by Hyuncheol Jung and Pascal Devant joint with @juliacarnevale.bsky.social

Risk-Based vs Annual Breast Cancer Screening This randomized clinical trial examines whether risk-based screening is a safe and effective alternative to annual mammography for detecting breast cancer in women 40 years and older.

Landmark study! WISDOM study demonstrated that a risk-based approach successfully stratifies the population for breast cancer risk and is safe and acceptable to women. @drlauraesserman.bsky.social. Risk-Based vs Annual Breast Cancer Screening url: jamanetwork.com/journals/jam...

Risk-Based Screening Works as Well as Yearly Checks After 40 in Finding Breast Cancers

"Probably the most important study that’s been presented at this meeting.” Dr. Eric Winer of @yalecancer.bsky.social comments on results from @wisdomstudy.bsky.social by lead author Dr. Laura Esserman @ucsfhealth.bsky.social at #SABCS2025 @sabcs.bsky.social www.nytimes.com/2025/12/12/h...

Today at 4pm | Friday Cancer Research Seminar: Aaron Hata, MD, PhD, Assistant Professor of Medicine @harvard.edu presents “Mechanisms driving evolution of drug resistance in lung cancer”
cancer.ucsf.edu/seminars

Health Affairs Journal

Nearly 1 in 3 insurance denials for cancer genetic testing overturned on appeal, finds new @ucsf-transpers.bsky.social
study of 941 cases across 4 states. Results reveal gaps between payer policies and clinical guidelines. @kathrynp-phd.bsky.social
www.healthaffairs.org/doi/10.1377/...

Real Impact with Artificial Intelligence:
Johan Hartman, Tufia Haddad, Amrita Basu, and advocate Carole L Baas explored this topic in an #SABCS25 educational session moderated by Frederick M Howard.

Genomic Maps Untangle the Complex Roots of Disease Findings of the new study in Nature could streamline scientific discovery and accelerate drug development.

Gladstone researcher Alex Marson and his collaborators at Stanford University developed a genomic mapping technique that helps close the gap in understanding why certain genetic variants are tied to disease.

@marsonlab.bsky.social
@stanford.edu
@nature.com

Applications are open for the 2026 CTCRE Postdoctoral Fellowship! Train with UCSF faculty and join a community committed to ending tobacco use. Apply today: tobacco.ucsf.edu/fellowship